Could antimicrobial therapy fight infections not only by targeting microbes but also by helping our immune cells function more effectively?
Researchers at the Institute of Microbiology and Virology of Rīga Stradiņš University (RSU), in collaboration with an international team of scientists, have discovered a promising link between cellular metabolism and the immune system's ability to fight infections. The RSU team included Emīls Edgars Bašēns, Trushnal Shrikant Waghmare, Georgy Nikolayshvili, Zaiga Nora-Krūkle and Bhupesh Kumar Prusty. Together with colleagues from Rutgers University, the University of Würzburg and other institutions, they investigated how the compound K21 – a quaternary ammonium silane compound with antibacterial, antiviral and antifungal activity – affects human immune cells and mitochondrial function. The study was published in the renowned journal Life Science Alliance.
The study results indicate that K21 alters immune cell metabolism, improves bacterial killing and promotes mitophagy – the recycling of mitochondria. A similar effect was also observed in the nematode Caenorhabditis elegans (a microscopic worm widely used in biological research), where it was associated with a longer lifespan.
The Immune System as a Stronger Ally in the Fight Against Microbes
Antimicrobial drugs usually target pathogens, for example, by disrupting the formation of bacterial cell walls, metabolism or reproduction. This research team asked a different question: how does K21 affect the host organism's immune cells?
The researchers focused on macrophages – adaptable immune cells that engulf microbes, coordinate inflammation and help repair tissues. Could K21's broad antimicrobial activity be partly linked to its ability to reprogram these cells?
Studying Immune Cells One Cell at a Time
The researchers obtained macrophages from human blood cells and studied their response to K21 using cytokine measurements, flow cytometry and single-cell RNA sequencing, which makes it possible to determine which genes are active in each cell.
Single-cell analysis revealed differences that go beyond the broad classification of macrophages into M1 and M2 groups. It made it possible to identify smaller cell populations and changes that could have gone unnoticed with traditional measurements.
Rather than converting one major macrophage type into another, K21 changed the balance of cell populations. It promoted populations with more pronounced inflammatory and pathogen-killing gene expression programs, while reducing others. These changes were not easily detectable by measuring only cytokines and cell surface markers.
A Clue Inside the Cell
Many of the changes pointed to mitochondria. These organelles not only produce energy but also influence metabolism, cell signalling and immunity, and they require constant maintenance.
During mitophagy, cells break down and recycle mitochondria. K21 promoted both the division of mitochondria into smaller units and mitophagy, apparently without causing the pronounced mitochondrial stress or damage characteristic of some other mitophagy-promoting compounds.
These results suggest a possible link between mitochondrial quality control and macrophage antimicrobial activity.
More Effective Fight Against Bacteria
To test this link, the researchers exposed macrophages to Enterococcus faecalis – a bacterium capable of surviving inside these cells. Before adding the bacteria, K21 was removed from the culture medium, helping to distinguish the effects on macrophages from direct effects on the bacteria.
The most pronounced effect was observed in M2 macrophages. Bacterial entry into the cells changed little, but bacteria recovered from K21-treated cells formed far fewer viable colonies. This suggests that the intracellular environment had become less favourable for bacterial infectivity.
Other mitophagy-promoting compounds also enhanced bacterial phagocytosis, a process in which immune cells engulf bacteria and take them inside. K21 stood out by combining improved mitochondrial quality control with a pronounced suppression of bacterial infectivity.
Microscopic Worms Lived Longer Under the Influence of K21
The team also tested the effects of K21 in a microscopic nematode, or worm, to determine whether they also occur in an evolutionarily distant organism.
In nematodes, K21 promoted DRP-1-dependent mitochondrial fission and mitophagy, similarly to human cells. Genetic experiments showed that these effects require the relevant mitochondrial and autophagy mechanisms, supporting the hypothesis of an evolutionarily conserved mechanism of action.
K21-treated nematodes also lived longer. The treatment did not adversely affect viability, development, growth or fertility, and the longer lifespan could not be explained by reduced food intake.
Why This Discovery Is Significant
The study suggests that future antimicrobial therapy could not only target pathogens but also strengthen the host organism's cellular defences. By influencing mitochondrial metabolism and quality control, it could improve pathogen killing and potentially help overcome traditional antimicrobial resistance.
The lifespan results also raise questions about cellular resilience and healthy ageing. However, an extended lifespan was demonstrated only in nematodes.
The precise molecular target of K21 remains unknown. The authors suggest that it may interact with mitochondrial membranes, but this hypothesis still needs to be tested.
A New Perspective on the Cell's Powerhouses
Mitochondria are more than just cellular batteries: their division and recycling link metabolism, immunity and lifespan. Understanding how K21 affects these mechanisms could help develop new therapeutic strategies.
The main idea – helping the body fight infection may begin not with attacking microbes, but with improving the functioning of our own cells' internal mechanisms.